Ximedica was recently featured in Insight Success’ “10 Most Recommended Pharma and Biotech Solution Providers 2018.” CEO Randy Barko was interviewed for the cover story, which illuminates how Ximedica is empowering healthcare with our innovative process, and also discussed what sets us apart from the competition.
“Ximedica’s full-service facilities and specialized team allow us to bring new products to market faster, more efficiently, and with greater market potential at every stage of the development process, from concept to commercialization,” said Barko. “We choose to devote our resources exclusively to expertise in the medical field because we felt we could have a meaningful influence on the entire healthcare ecosystem.”
Ximedica is a full-service ISO 13485-certified and FDA-registered medical device and diagnostics product development firm. For 30 years Ximedica has provided a unique growth platform enabling organizations to successfully deploy medical technology products into the market. Its headquarters are in Providence, R.I., with offices in Hong Kong, Minneapolis, San Francisco and Los Gatos. In November of 2014, SV LifeSciences, a Boston-based private equity firm, acquired a majority stake in Ximedica, enabling the company to execute its growth strategy.
To read the full article, please visit http://magazines.insightssuccess.com/The-10-Most-Recommended-Pharma-Biotech-Solution-Providers-2018-June2018/.